Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Revenues		$ 366		$ 7,803
Operating expenses:
Research and development	8	814	41	7,160
General and administrative	858	2,209	4,220	5,836
Loss on MannKind Transaction				2,618
Total operating expenses	866	3,023	4,261	15,614
Loss from operations	(866)	(2,657)	(4,261)	(7,811)
Other income (expense):
Interest income	30	101	124	394
Fair value adjustment of warrants			67
Other expense, net	(41)	(31)	(164)	(156)
Total other income (expense), net	(11)	70	27	238
Net loss	$ (877)	$ (2,587)	$ (4,234)	$ (7,573)
Net loss per share attributable to common stockholders basic	$ (0.24)	$ (0.71)	$ (1.16)	$ (2.07)
Net loss per share attributable to common stockholders diluted	$ (0.24)	$ (0.71)	$ (1.16)	$ (2.07)
Weighted average common shares outstanding basic	3,652,285	3,652,285	3,652,285	3,652,285
Weighted average common shares outstanding diluted	3,652,285	3,652,285	3,652,285	3,652,285